Literature DB >> 12937162

Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol.

Manal Zabalawi1, Shaila Bhat, Tara Loughlin, Michael J Thomas, Eric Alexander, Mark Cline, Bill Bullock, Mark Willingham, Mary G Sorci-Thomas.   

Abstract

Atherogenic response to dietary fat and cholesterol challenge was evaluated in mice lacking both the LDL receptor (LDLr(-/-)) and apoA-I (apoA-I(-/-)) gene, LDLr(-/-)/apoA-I(-/-) or double-knockout mice. Gender- and age-matched LDLr(-/-)/apoA-I(-/-) mice were fed a diet consisting of 0.1% cholesterol and 10% palm oil for 16 weeks and compared to LDLr(-/-) mice or single-knockout mice. The LDLr(-/-) mice showed a 6- to 7-fold increase in total plasma cholesterol (TPC) compared to their chow-fed mice counterparts, while LDLr(-/-)/apoA-I(-/-) mice showed only a 2- to 3-fold increase in TPC compared to their chow-fed controls. This differential response to the atherogenic diet was unanticipated, since chow-fed LDLr(-/-) and LDLr(-/-)/apoA-I(-/-) mice began the study with similar LDL levels and differed primarily in their HDL concentration. The 6-fold diet-induced increase in TPC observed in the LDLr(-/-) mice occurred mainly in VLDL/LDL and not in HDL. Mid-study plasma samples taken after 8 weeks of diet feeding showed that LDLr(-/-) mice had TPC concentrations approximately 60% of their 16-week level, while the LDLr(-/-)/apoA-I(-/-) mice had reached 100% of their 16-week TPC concentration after only 8 weeks of diet. Male LDLr(-/-) mice showed similar aortic cholesterol levels to male LDLr(-/-)/apoA-I(-/-) mice despite a 4-fold higher VLDL/LDL concentration in the LDLr(-/-) mice. A direct comparison of the severity of aortic atherosclerosis between female LDLr(-/-) and LDLr(-/-)/apoA-I(-/-) mice was compromised due to the loss of female LDLr(-/-)/apoA-I(-/-) mice between 10 and 14 weeks into the study. Diet-fed female and, with time, male LDLr(-/-)/apoA-I(-/-) mice suffered from severe ulcerated cutaneous xanthomatosis. This condition, combined with a complete depletion of adrenal cholesterol, manifested in fatal wasting of the affected mice. In conclusion, LDLr(-/-) and LDLr(-/-)/apoA-I(-/-) mice showed dramatic TPC differences in response to dietary fat and cholesterol challenge, while despite these differences both genotypes accumulated similar levels of aortic cholesterol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937162      PMCID: PMC1868257          DOI: 10.1016/S0002-9440(10)63480-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

Authors:  J J Badimon; L Badimon; V Fuster
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 2.  The effects of altered apolipoprotein A-I structure on plasma HDL concentration.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

3.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

Authors:  G R Warnick; J Benderson; J J Albers
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

4.  Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks.

Authors:  Giulia Chiesa; Elena Monteggia; Marta Marchesi; Paolo Lorenzon; Massimo Laucello; Vito Lorusso; Carlo Di Mario; Evangelia Karvouni; Roger S Newton; Charles L Bisgaier; Guido Franceschini; Cesare R Sirtori
Journal:  Circ Res       Date:  2002-05-17       Impact factor: 17.367

5.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

Authors:  E M Rubin; B Y Ishida; S M Clift; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

6.  Rat adrenal uptake and metabolism of high density lipoprotein cholesteryl ester.

Authors:  J T Gwynne; D D Mahaffee
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

7.  The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis.

Authors:  J T Gwynne; B Hess
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

8.  High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.

Authors:  A Walsh; Y Ito; J L Breslow
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

9.  Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.

Authors:  R Williamson; D Lee; J Hagaman; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

View more
  29 in total

1.  Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.

Authors:  Mary G Sorci-Thomas; Manal Zabalawi; Manish S Bharadwaj; Ashley J Wilhelm; John S Owen; Bela F Asztalos; Shaila Bhat; Michael J Thomas
Journal:  Biochim Biophys Acta       Date:  2011-09-14

Review 2.  HDL, lipid peroxidation, and atherosclerosis.

Authors:  Baohai Shao; Jay W Heinecke
Journal:  J Lipid Res       Date:  2009-01-12       Impact factor: 5.922

3.  Using Mendelian Randomization studies to Assess Causality and Identify New Therapeutic Targets in Cardiovascular Medicine.

Authors:  Wei Zhao; Jung-Jin Lee; Asif Rasheed; Danish Saleheen
Journal:  Curr Genet Med Rep       Date:  2016-09-10

4.  Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL.

Authors:  Hagai Tavori; Yan Ru Su; Patricia G Yancey; Ilaria Giunzioni; Ashley J Wilhelm; John L Blakemore; Manal Zabalawi; MacRae F Linton; Mary G Sorci-Thomas; Sergio Fazio
Journal:  J Lipid Res       Date:  2015-01-15       Impact factor: 5.922

Review 5.  Genetic basis of atherosclerosis: insights from mice and humans.

Authors:  Ioannis M Stylianou; Robert C Bauer; Muredach P Reilly; Daniel J Rader
Journal:  Circ Res       Date:  2012-01-20       Impact factor: 17.367

6.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

7.  Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation.

Authors:  Hiroyasu Sato; Yoshitaka Taketomi; Yuki Isogai; Seiko Masuda; Tetsuyuki Kobayashi; Kei Yamamoto; Makoto Murakami
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

8.  Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity.

Authors:  Ashley J Wilhelm; Manal Zabalawi; Jason M Grayson; Ashley E Weant; Amy S Major; John Owen; Manish Bharadwaj; Rosemary Walzem; Lawrence Chan; Kazuhiro Oka; Michael J Thomas; Mary G Sorci-Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-12       Impact factor: 8.311

Review 9.  High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

10.  Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.

Authors:  Tomás Vaisar; Baohai Shao; Pattie S Green; Michael N Oda; John F Oram; Jay W Heinecke
Journal:  Curr Atheroscler Rep       Date:  2007-11       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.